Screener
Sana Biotechnology SANA Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| General and administrative | 11,462 | 11,484 |
| Total operating expenses | 48,614 | 50,630 |
| Loss from operations | (48,614) | (50,630) |
| Interest income, net | 951 | 992 |
| Other income, net | 453 | 249 |
| Net loss | $(47,210) | $(49,389) |
| Net loss per common share – basic and diluted | $(0.17) | $(0.21) |
| Weighted-average number of common shares – basic and diluted | 276,856 | 237,578 |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's other income (expense)?
- Sana Biotechnology (SANA) reported other income (expense) of $453K in Q1 2026.
- How has Sana Biotechnology's other income (expense) changed year-over-year?
- Sana Biotechnology's other income (expense) increased by 81.9% year-over-year, from $249K to $453K.
- What is the long-term trend for Sana Biotechnology's other income (expense)?
- Over 4 years (2021 to 2025), Sana Biotechnology's other income (expense) has grown at a 65.8% compound annual growth rate (CAGR), from $305K to $2.31M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Sana Biotechnology's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude